Clinical Use of Dexamethasone Implants in Resistant Macular Edema Secondary to Branch Retinal Vascular Occlusion Compared with Intravitreal Anti-Vascular Endothelial Growth Factor

Clinical Use of Dexamethasone Implants in Resistant Macular Edema Secondary to Branch Retinal Vascular Occlusion Compared with Intravitreal Anti-Vascular Endothelial Growth Factor

INTRODUCTION[|]Branch retinal vein occlusion (BRVO) is the second most common type of retinal vascular disorder. Both inflammation and increased vascular endothelial growth factor (VEGF) levels play important roles in the pathogenesis of macular edema (ME) secondary to BRVO. The aim of this study wa...

Full description

Bibliographic Details
Main Authors: Erdem Eris, Irfan Perente, Gurkan Erdogan, Zeynep Seymen, Mehmet Emin Sucu, Abdullah Ozkaya, Ali Demircan, Zeynep Alkin, Ahmet Demirok, Ozgur Artunay
Format: Article
Language:English
Published: KARE Publishing 2019-04-01
Series:Beyoglu Eye Journal
Subjects:
branch retinal vascular occlusion dexamethasone implant
macular edema
ranibizumab.
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=beyoglu&un=BEJ-63835

Internet

https://jag.journalagent.com/z4/download_fulltext.asp?pdir=beyoglu&un=BEJ-63835

Similar Items